Literature DB >> 11545264

The astrocyte/meningeal cell interface--a barrier to successful nerve regeneration?

M C Shearer1, J W Fawcett.   

Abstract

Following injuries to the adult mammalian CNS meningeal cells migrate into the lesion cavity, forming a fibrotic scar and accessory glia limitans. This infiltration re-establishes the meningeal layer that normally surrounds the CNS, and so reforms the barrier between the CNS and external environment, thus protecting the damaged region from events outside it. However, the newly formed meningeal layer and glia limitans may impede subsequent nerve regeneration through the injured region. This structure can be modelled in vitro using an astrocyte/meningeal co-culture system. We have examined patterns of neurite outgrowth on such cultures, and we find that axons cross readily from meningeal cells to astrocytes, but are unwilling to cross in the other direction. The distribution of cell surface and matrix molecules on these cultures is described, and the effect of various pharmacological interventions which can affect axon growth between the two cell types is summarised in this review.

Entities:  

Mesh:

Year:  2001        PMID: 11545264     DOI: 10.1007/s004410100384

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  49 in total

Review 1.  Axon Guidance Molecules and Neural Circuit Remodeling After Spinal Cord Injury.

Authors:  Edmund R Hollis
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

2.  EphA4 deficient mice maintain astroglial-fibrotic scar formation after spinal cord injury.

Authors:  Julia E Herrmann; Ravi R Shah; Andrea F Chan; Binhai Zheng
Journal:  Exp Neurol       Date:  2010-02-17       Impact factor: 5.330

Review 3.  Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Authors:  Conrad E Johanson; John A Duncan; Edward G Stopa; Andrew Baird
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

Review 4.  Semaphorins in axon regeneration: developmental guidance molecules gone wrong?

Authors:  R Jeroen Pasterkamp; Joost Verhaagen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

5.  Immunohistochemical analysis of TIMP-2 and collagen types I and IV in experimental spinal cord ischemia-reperfusion injury in rats.

Authors:  Ihsan Anik; Sibel Kokturk; Hamza Genc; Burak Cabuk; Kenan Koc; Sadan Yavuz; Sureyya Ceylan; Savas Ceylan; Levent Kamaci; Yonca Anik
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

6.  Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision.

Authors:  Rutledge G Ellis-Behnke; Yu-Xiang Liang; Si-Wei You; David K C Tay; Shuguang Zhang; Kwok-Fai So; Gerald E Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

7.  Perivascular fibroblasts form the fibrotic scar after contusive spinal cord injury.

Authors:  Cynthia Soderblom; Xueting Luo; Ezra Blumenthal; Eric Bray; Kirill Lyapichev; Jose Ramos; Vidhya Krishnan; Catherine Lai-Hsu; Kevin K Park; Pantelis Tsoulfas; Jae K Lee
Journal:  J Neurosci       Date:  2013-08-21       Impact factor: 6.167

8.  Short hairpin RNA against PTEN enhances regenerative growth of corticospinal tract axons after spinal cord injury.

Authors:  Katherine Zukor; Stephane Belin; Chen Wang; Nadia Keelan; Xuhua Wang; Zhigang He
Journal:  J Neurosci       Date:  2013-09-25       Impact factor: 6.167

9.  Failure mode analysis of silicon-based intracortical microelectrode arrays in non-human primates.

Authors:  James C Barrese; Naveen Rao; Kaivon Paroo; Corey Triebwasser; Carlos Vargas-Irwin; Lachlan Franquemont; John P Donoghue
Journal:  J Neural Eng       Date:  2013-11-12       Impact factor: 5.379

10.  Fibronectin Matrix Assembly after Spinal Cord Injury.

Authors:  Yunjiao Zhu; Cynthia Soderblom; Michelle Trojanowsky; Do-Hun Lee; Jae K Lee
Journal:  J Neurotrauma       Date:  2015-03-09       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.